Cite
HARVARD Citation
, . et al. (2018). Pyronaridine–artesunate or dihydroartemisinin–piperaquine versus current first-line therapies for repeated treatment of uncomplicated malaria: a randomised, multicentre, open-label, longitudinal, controlled, phase 3b/4 trial. Lancet. 391 (10128), pp. 1378-1390. [Online].